PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-17

  1. 761 Posts.
    lightbulb Created with Sketch. 147
    This is a good outcome. 5/6 questions resolved 1 more to go. An extra 60'days is absolutely nothing in the scheme of what is being achieved here.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.